ProteoMediX raised €4.6M in a Series C round in Aug 2016. The company is based in Schlieren, Switzerland. Investors in the round: Altos Ventures. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €4.6M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
